Radiopharm Theranostics Files 6-K
Ticker: RDPTF · Form: 6-K · Filed: Jun 4, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Jun 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
Radiopharm Theranostics filed a 6-K on June 4, 2025, standard SEC reporting.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on June 4, 2025, reporting information for the month of June 2025. The company is a foreign private issuer and is not furnishing information under Rule 12g3-2(b). The filing is related to its operations and compliance with SEC regulations.
Why It Matters
This filing indicates ongoing compliance and reporting by Radiopharm Theranostics Limited as a foreign private issuer with the SEC.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain specific financial or operational disclosures that would indicate immediate risk.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — SEC File Number
- June 4, 2025 (date) — Filing Date
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
Who is the registrant?
The registrant is Radiopharm Theranostics Limited.
What is the SEC file number for this registrant?
The SEC file number is 001-41621.
Is Radiopharm Theranostics furnishing information under Rule 12g3-2(b)?
No, the company indicated it is not furnishing information under Rule 12g3-2(b).
What is the principal executive office address?
The address is Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 4, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).